We are live on ! Find out more
VTGN icon

VistaGen Therapeutics
VTGN

22 hedge funds and large institutions have $1.02M invested in VistaGen Therapeutics in 2020 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 7 increasing their positions, 1 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

600% more repeat investments, than reductions

Existing positions increased: 7 | Existing positions reduced: 1

0.04% less ownership

Funds ownership: 0.19% → 0.15% (-0.04%)

12% less funds holding

Funds holding: 25 → 22 (-3)

33% less first-time investments, than exits

New positions opened: 2 | Existing positions closed: 3

42% less capital invested

Capital invested by funds: $1.76M → $1.02M (-$740K)

Holders
22
Holders Change
-3
Holders Change %
-12%
% of All Funds
0.48%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
7
Reduced
1
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
LPL Financial
LPL Financial
California
+$9.16K
2
Northern Trust
Northern Trust
Illinois
+$6.13K
3
UBS Group
UBS Group
Switzerland
+$5.22K
4
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$3.74K
5
BlackRock
BlackRock
New York
+$1.74K

Top Sellers

Rank Fund Capital Flow
1
Wells Fargo
Wells Fargo
California
-$91.4K
2
TSS
Two Sigma Securities
New York
-$51K
3
William Blair & Company
William Blair & Company
Illinois
-$35K
4
RC
RBF Capital
California
-$19K
Name Holding Trade Value Shares
Change 		Change in
Stake
Vanguard Group
1
Vanguard Group
Pennsylvania
$531K +$1.47K +80 +0.2%
Geode Capital Management
2
Geode Capital Management
Massachusetts
$110K +$1.26K +69 +0.8%
Osaic Holdings
3
Osaic Holdings
Arizona
$75K +$105K +5,714 New
HighTower Advisors
4
HighTower Advisors
Illinois
$58K – – –
DADC
5
D.A. Davidson & Co
Montana
$48K – – –
Carson Wealth (CWM LLC)
6
Carson Wealth (CWM LLC)
Nebraska
$43K – – –
Northern Trust
7
Northern Trust
Illinois
$35K +$6.13K +335 +14%
Parallax Volatility Advisers
8
Parallax Volatility Advisers
California
$20K – – –
LPL Financial
9
LPL Financial
California
$18K +$9.16K +500 +60%
BlackRock
10
BlackRock
New York
$15K +$1.74K +95 +9%
UBS Group
11
UBS Group
Switzerland
$13K +$5.22K +285 +43%
FAIM
12
Financial Advocates Investment Management
Washington
$10K – – –
GBA
13
Garrison Bradford & Associates
New York
$9K – – –
Koshinski Asset Management
14
Koshinski Asset Management
Illinois
$9K – – –
Susquehanna International Group
15
Susquehanna International Group
Pennsylvania
$9K +$3.74K +204 +45%
HFM
16
Hartford Financial Management
Connecticut
$7K – – –
Morgan Stanley
17
Morgan Stanley
New York
$6K – – –
Commonwealth Equity Services
18
Commonwealth Equity Services
Massachusetts
$5K – – –
JMPWA
19
JP Morgan Private Wealth Advisors
California
$4K – – –
Wells Fargo
20
Wells Fargo
California
– -$91.4K -4,990 -100%
TSS
21
Two Sigma Securities
New York
– -$51K -2,441 Closed
William Blair & Company
22
William Blair & Company
Illinois
– -$35K -1,705 Closed
RC
23
RBF Capital
California
– -$19K -833 Closed
GI
24
Gradient Investments
Minnesota
– +$55 +3 New

VTGN Hedge Fund Activity: Q1 2020 in Review

22 of the 4,538 institutional investors tracked by Wall St. Rank reported a position in VistaGen Therapeutics (VTGN) for Q1 2020, worth a combined $1.02M — down 42% from $1.76M a quarter earlier.

Sellers outnumbered buyers: 3 funds closed out of VTGN and 2 opened new positions — a net loss of 1 holder — while 1 trimmed existing stakes and 7 added.

The largest buyer was LPL Financial, adding an estimated $9.16K. The largest seller was Wells Fargo, cutting an estimated $91.4K.

  • 22 institutional investors held VistaGen Therapeutics (VTGN) as of Q1 2020, down from 25 in Q4 2019.
  • Funds reported $1.02M of VistaGen Therapeutics stock for Q1 2020, down 42% quarter-over-quarter.
  • 2 funds opened new VistaGen Therapeutics positions in Q1 2020 and 3 closed out, a net change of -1 holder.
  • The largest VistaGen Therapeutics buyer in Q1 2020 was LPL Financial, an estimated $9.16K added.
  • The largest VistaGen Therapeutics seller in Q1 2020 was Wells Fargo, an estimated $91.4K sold.

Based on aggregated 13F filings for Q1 2020.